Recent years have brought revolutionary innovations in lung cancer treatment. A group of biological drugs called checkpoint inhibitors—monoclonal antibodies—or IMMUNOTHERAPY, have become an important part of lung cancer treatment. These drugs activate the immune system's fighting cells (T lymphocytes) to attack the tumor. These drugs either bind to the PD-1 receptor on T lymphocytes (Anti-PD-1 blockers)

Cancer is a disease that has existed since the dawn of humanity. The first steps in modern cancer treatment were taken after World War II. The successful use of drugs in cancer treatment began in the 1970s. The treatment of cancer with drugs is called chemotherapy, and these drugs are called chemotherapy drugs. The most important reason for using drug therapy in cancer treatment is that cancer is generally a systemic disease (i.e., it affects many parts of the body).

Cancer has existed on Earth since the dawn of humanity. With the increase in human lifespan and the decrease in deaths from infectious diseases, cancer became one of the most common diseases of the 20th century. The decline in deaths from heart and vascular diseases over the past decade and the fact that they will be less common in the future will make cancer the most important disease of the 21st century. Cancer occurs when a cell in our body, one day, for no apparent reason,

Breast cancer is the most common type of cancer in women. In developed countries, one in every 7-8 women who live to the age of 70 will develop breast cancer. Although the exact figures are unknown in our country, it is an inevitable fact that the incidence of breast cancer will increase due to increasing industrialization and changing dietary habits. Three-quarters of women diagnosed with breast cancer have no specific risk factors other than being female.

Lung cancer has gone down in world history as one of the most significant diseases of the 20th century. Both statistically and biologically, it has been proven that smoking is the most important cause of this disease. Following trends toward smoking cessation in Western countries, a decline in the incidence of lung cancer cases has emerged, at least among men. Among women, deaths from lung cancer have surpassed those from breast cancer in number. Last year